Logo

People in the News: David Baulcombe

Sep 13, 2012
Premium

The International Balzan Foundation has named University of Cambridge researcher and RNA silencing pioneer David Baulcombe a 2012 Balzan Prize winner.

Baulcombe was named a winner for his “fundamental contribution to the understanding of epigenetics and its role in cell and tissue development under normal and stressful conditions,” the foundation said.

The prize comes with a 750,000 Swiss franc ($790,000) award.

Filed under

Gene Silencing/Gene Editing
Epigenetics Research
epigenetics
RNAi
Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.